<DOC>
	<DOCNO>NCT00053404</DOCNO>
	<brief_summary>Drug resistant HIV strain often develop patient take anti-HIV drug extend time . However , drug resistant HIV strain always cause increase level HIV blood . This study explore patient drug resistant virus continue low viral load .</brief_summary>
	<brief_title>Immunologic Control Drug Resistant HIV</brief_title>
	<detailed_description>Despite emergence high level drug resistance HIV-infected patient stable antiretroviral therapy , plasma HIV RNA level generally remain pretherapy viral load `` set-point '' . The virologic immunologic determinant low steady state level viremia define . Preliminary data indicate : 1 ) drug resistant variant reduce replicative capacity pathogenic potential ; 2 ) drug resistant viremia associate reduce T cell activation turnover compare wild-type viremia ; 3 ) patient low level drug resistant viremia often HIV-specific CD4 cell absent patient high level viremia . This study investigate whether emergence poorly fit , drug resistant variant result generation effective HIV-specific CD4 cell response response contribute establishment low steady state level viremia . Participants study follow 2 year antiretroviral therapy modify discontinue . Study visit occur every 2 month , total 14 visit . Study visit include patient interview blood test measure breadth magnitude HIV-specific CD4 CD8 cell response function viral load , viral replicative capacity , drug resistance phenotype , T cell turnover , thymic function .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>HIVinfected least 6 month prior study entry Documented pretherapy offtherapy viral load 10,000 copies/ml least 2 occasion 20,000 copies/ml least 1 occasion At least 70 % reduction plasma HIV RNA level pretherapy baseline Stable highly active antiretroviral therapy ( HAART ) regimen least 4 month prior study entry HIV viral load 200 10,000 copies/ml 3 month prior study entry CD4 count great 100 cells/mm3 nadir CD4 count le 500 cells/mm3 Virologic failure define DHHS guideline least one HAART regimen prior study entry HAART regimen Documented adherence antiretroviral therapy Two major resistance mutation least two antiretroviral drug class Significant toxicity current HAART regimen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Treatment Experienced</keyword>
	<keyword>Drug Resistance</keyword>
</DOC>